CIK 0000882095 · Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943047598
- Phone
- 6505743000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $39,503,648
- in 13 filings, $39.5M under 10b5-1 plans
Net −$39,503,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- O'Day Daniel Patrick −$29.5M Chairman & CEO sold 24% of stake
- Mercier Johanna −$4.8M Chief Comm & Corp Aff Officer sold 23% of stake
- WELTERS ANTHONY −$2.7M Director sold 58% of stake
- Dickinson Andrew D −$1.3M Chief Financial Officer sold 5% of stake
- Bluestone Jeffrey −$725K Director sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-10 | Dickinson Andrew D Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,797 | 25,054 | ||
| 2026-09-01 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −1,600 | $147.51 | $236K | 590,533 |
| 2026-09-01 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −7,992 | $148.36 | $1.2M | 582,541 |
| 2026-09-01 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −5,408 | $149.38 | $808K | 577,133 |
| 2026-08-26 | WELTERS ANTHONY Director | Option exercise 10b5-1 | +7,718 | $60.67 | $468K | 20,612 |
| 2026-08-26 | WELTERS ANTHONY Director | Sale 10b5-1 | −3,118 | $148.31 | $462K | 17,494 |
| 2026-08-26 | WELTERS ANTHONY Director | Sale 10b5-1 | −4,600 | $148.82 | $685K | 12,894 |
| 2026-08-26 | WELTERS ANTHONY Director | Option exercise 10b5-1 | +10,282 | $61.35 | $631K | 23,176 |
| 2026-08-26 | WELTERS ANTHONY Director | Sale 10b5-1 | −3,402 | $148.24 | $504K | 19,774 |
| 2026-08-26 | WELTERS ANTHONY Director | Sale 10b5-1 | −6,880 | $148.82 | $1.0M | 12,894 |
| 2026-08-26 | WELTERS ANTHONY Director | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −7,718 | 0 | ||
| 2026-08-26 | WELTERS ANTHONY Director | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −10,282 | 5,569 | ||
| 2026-08-20 | Bluestone Jeffrey Director | Option exercise 10b5-1 | +1,165 | $67.45 | $79K | 11,231 |
| 2026-08-20 | Bluestone Jeffrey Director | Sale 10b5-1 | −1,165 | $143.75 | $167K | 10,066 |
| 2026-08-20 | Bluestone Jeffrey Director | Option exercise 10b5-1 | +1,816 | $67.45 | $122K | 11,882 |
| 2026-08-20 | Bluestone Jeffrey Director | Sale 10b5-1 | −1,816 | $144.92 | $263K | 10,066 |
| 2026-08-20 | Bluestone Jeffrey Director | Option exercise 10b5-1 | +1,658 | $67.45 | $112K | 11,724 |
| 2026-08-20 | Bluestone Jeffrey Director | Sale 10b5-1 | −1,658 | $145.73 | $242K | 10,066 |
| 2026-08-20 | Bluestone Jeffrey Director | Option exercise 10b5-1 | +26 | $67.45 | $2K | 10,092 |
| 2026-08-20 | Bluestone Jeffrey Director | Sale 10b5-1 | −26 | $146.36 | $4K | 10,066 |
Page 3 of 30 · 584 trades